Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.

Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.

Detalhes bibliográficos
Principais autores:	Petersen, SE, Watkins, H, Neubauer, S
Formato:	Journal article
Idioma:	English
Publicado em:	2009

Registros relacionados

Left and right ventricular tissue velocities are reduced in hypertrophic cardiomyopathy but not in athlete's heart
por: Petersen, SE, et al.
Publicado em: (2008)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
por: Hudsmith, L, et al.
Publicado em: (2006)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
por: Kramer, CM, et al.
Publicado em: (2018)

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.
por: Crilley, J, et al.
Publicado em: (2003)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
por: Raman, B, et al.
Publicado em: (2018)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
por: Ashrafian, H, et al.
Publicado em: (2005)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
por: Rayner, JJ, et al.
Publicado em: (2020)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
por: Ariga, R, et al.
Publicado em: (2019)

Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy
por: Aung, N, et al.
Publicado em: (2023)

Non-invasive imaging of myocardial disarray associates with ventricular arrhythmia in hypertrophic cardiomyopathy
por: Ariga, R, et al.
Publicado em: (2017)

Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: stunning by any other name?
por: Ashrafian, H, et al.
Publicado em: (2008)

Left ventricular strain is abnormal in preclinical and overt hypertrophic cardiomyopathy: Cardiac MR feature tracking
por: Vigneault, DM, et al.
Publicado em: (2018)

The growth hormone inducible transmembrane gene is a novel genetic modifier of left ventricular hypertrophy in families with hypertrophic cardiomyopathy
por: Parker, M, et al.
Publicado em: (2009)

Sudden death in hypertrophic cardiomyopathy.
por: Watkins, H
Publicado em: (2000)

Myocardial dysfunction in hypertrophic cardiomyopathy.
por: Ashrafian, H, et al.
Publicado em: (2001)

Hypertrophic cardiomyopathy complicated by large apical aneurysm and thrombus, presenting as ventricular tachycardia.
por: Holloway, C, et al.
Publicado em: (2010)

Left ventricular thrombi in a patient with left ventricular non-compaction in visualisation of the rationale for anticoagulation.
por: Petersen, SE, et al.
Publicado em: (2005)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
por: Ashrafian, H, et al.
Publicado em: (2003)

ACUTE DERANGEMENT OF CARDIAC ENERGY METABOLISM AND OXYGENATION DURING STRESS IN HYPERTROPHIC CARDIOMYOPATHY-A POTENTIAL MECHANISM FOR SUDDEN CARDIAC DEATH
por: Dass, S, et al.
Publicado em: (2012)

The role of cardiac energy metabolism and during stress in hypertrophic and dilated cardiomyopathy.
por: Dass, S
Publicado em: (2012)

The genetics of hypertrophic cardiomyopathy: Teare redux.
por: Watkins, H, et al.
Publicado em: (2008)

Insights into mechanisms and clinical implications of myocardial fibrosis and its progression in hypertrophic cardiomyopathy
por: Raman, B
Publicado em: (2019)

Tako-tsubo cardiomyopathy presenting with features of left ventricular non-compaction.
por: Karamitsos, T, et al.
Publicado em: (2008)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
por: Abozguia, K, et al.
Publicado em: (2010)

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric MRI
por: Petersen, S, et al.
Publicado em: (2007)

Linked genetic modifiers in hypertrophic cardiomyopathy
por: Ektisham, J, et al.
Publicado em: (2004)

Metabolic Modulation With Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy
por: Abozguia, K, et al.
Publicado em: (2009)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
por: Dass, S, et al.
Publicado em: (2012)

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.
por: Abozguia, K, et al.
Publicado em: (2010)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
por: Suttie, J, et al.
Publicado em: (2011)

Derangement of cardiac high energy phosphate metabolism in patients with left ventricular non-compaction and preserved ejection fraction
por: Petersen, S, et al.
Publicado em: (2006)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
por: Watkins, H
Publicado em: (2003)

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
por: Petersen, SE, et al.
Publicado em: (2007)

Influence of left ventricular pressures and heart rate on myocardial high-energy phosphate metabolism.
por: Neubauer, S
Publicado em: (1998)

Ventricular hypertrophic response precedes ventricular cavity dilatation in response to increasing body mass index
por: Rider, O, et al.
Publicado em: (2008)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
por: Watkins, H, et al.
Publicado em: (2005)

Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management
por: Watkins, H
Publicado em: (2001)

Assigning a causal role to genetic variants in hypertrophic cardiomyopathy.
por: Watkins, H
Publicado em: (2013)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
por: Blair, E, et al.
Publicado em: (2003)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
por: Ashrafian, H, et al.
Publicado em: (2011)